Related Experiment Video
Updated: Feb 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Denosumab-Associated Severe Hypocalcemia in a Patient With Chronic Kidney Disease
Sohail Abdul Salim1, Lakshmi Ramachandran Nair2, Litty Thomas1
1Department of Internal Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi.
Abstract:
Denosumab is a monoclonal antibody directed against the receptor activator of nuclear factor kappa B ligand (RANKL). Denosumab has been shown to reduce the risk of skeletal-related events, including spinal cord compression, pathologic fracture and hypercalcemia of malignancy in patients with bone metastases. Hypocalcemia is a known side effect of denosumab, occurring in an estimated 8-14% of the patients. Here, we present an asymptomatic patient with stage-5 chronic kidney disease and severe hypocalcemia who had received denosumab 1 month earlier.
Insights
Denosumab, a bone metastasis treatment, can cause hypocalcemia. This case study highlights severe, asymptomatic hypocalcemia in a patient with chronic kidney disease after denosumab treatment.
Area of Science:
- Oncology
- Nephrology
- Pharmacology
Background:
- Denosumab is a monoclonal antibody targeting RANKL, used to prevent skeletal events in bone metastases.
- Hypocalcemia is a recognized side effect of denosumab, affecting 8-14% of patients.
- Chronic kidney disease (CKD) can exacerbate calcium dysregulation.
More Related Videos
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation